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ABSTRACT
The role of thromboxane (TP) in the vasoconstriction induced by tubuloglomerular feedback or 18-h
ureteral obstruction was studied in wild type mice (TP +/+), and in heterozygous (TP +/±) and
homozygous TP receptor knockout mice (TPR ±/±). TGF function was assessed from the response of
stop flow pressure (PSF) to a maximum increase in loop of Henle ¯ow rate (0±30 nL min
±1). PSF fell by
6.4  0.4 mmHg in wild-type mice, by 6.1  0.6 mmHg in TP +/±, and by 7.9  0.7 mmHg in TP ±/±
mice. In the presence of the TP receptor agonist U46,619 (10±5 M) the PSF reduction increased to
10.4  0.8 mmHg in TP +/+, and to 10.6  2.8 mmHg in TP +/±, but was unchanged at
7.7  0.7 mmHg in TP ±/±. Mean arterial blood pressures were comparable between groups
(103  3 mmHg in TP +/+, 113  4.6 in TP +/± and 113  2.4 mmHg in TP ±/± mice). Intratubular
pressure following unilateral ureteral obstruction was signi®cantly higher in TP ±/± than in TP +/+
mice both in the early phase (0±3 h) and late phase (18 h) of obstruction. These results indicate that
chronic TP receptor de®ciency does not signi®cantly alter maximum TGF responses in mice, and that
it is accompanied by exaggerated vasodilatation during short-term unilateral ureteral obstruction and
attenuated vasoconstriction during longer lasting obstruction. We conclude that thromboxane is
primarily a regulator of renal vascular tone under pathophysiological conditions.
Keywords knockout mice, micropuncture, thromboxane, tubuloglomerular feedback, ureteral
obstruction, vasoconstriction.
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The metabolism of arachidonic acid in the kidney by
cyclooxygenases is associated with the production of
prostanoid compounds that play a role in the local
regulation of vascular resistance, tubular transport and
hormone release (Breyer & Badr 1996). Prostaglandin
generation is a property of essentially all vascular and
epithelial structures in the kidney, but the quantitative
distribution within the prostaglandin spectrum is cell-
speci®c. In the glomerular region, the major prosta-
glandins generated under physiological conditions are
PGE2 and PGI2 while PGF2a and thromboxane are
produced at lower rates (Farman et al. 1987, Schlon-
dorff & Ardaillou 1986). While PGE2 and PGI2 have
vasorelaxant properties, thromboxane A2 is a vaso-
constrictor of most arteries and arterioles including the
afferent arterioles of the glomerulus (Loutzenhiser et al.
1986). While the role of thromboxane in determining
vascular tone under resting conditions in a normal
kidney is probably small, there is considerable evidence
to suggest that thromboxane importantly contributes to
the vasoconstriction seen in a number of renal disease
states (Remuzzi et al. 1992). For example, the increase
in renal vascular resistance that develops during ureteral
obstruction is to a major extent the consequence of
increased production of thromboxane A2 (Morrison
et al. 1977). Nevertheless, there is also evidence to
indicate that thromboxane contributes to the vasocon-
striction that results from an increase in NaCl
concentration at the macula densa, the tubuloglomer-
ular feedback response (Welch & Wilcox 1988).
The recent generation of mice with a knockout
mutation in the thromboxane prostanoid (TP) receptor
Correspondence: Dr JuÈrgen Schnermann, NIDDK, NIH, Building 10, Room 4D51, 10 Center Drive MSC 1370, Bethesda, MD 20892-1370,
USA.
Acta Physiol Scand 2000, 168, 201±207
Ó 2000 Scandinavian Physiological Society 201
gene has created a tool to assess the role of complete
absence of functional TP receptors on renal vasocon-
strictor responses in a new way (Thomas & Coffman
1998, Thomas et al. 1998). TP receptor knockout mice
show the expected abnormalities in coagulation time
and platelet aggregation, but they are viable and pheno-
typically largely normal (Thomas et al. 1998). Notably,
they do not seem to have a reduced blood pressure or
an obvious alteration of renal function (Thomas et al.
1998). The current experiments were performed to
investigate (1) if TP receptor knockout mice have a
reduced tubuloglomerular feedback response as one
would expect if thromboxane was an important con-
stituent of the TGF constrictor pathway, and (2) if TP
receptor knockout mice have a drastically altered
vasoconstriction in response to ureteral obstruction.
Our data indicate that chronic absence of TP receptors
does not affect the TGF response magnitude, but that
it has an attenuating effect on the vasoconstriction
resulting from persistent ureteral obstruction.
METHODS
Experiments were performed in wild-type, hetero-
zygous and homozygous mice of a strain carrying a null
mutation in the TP receptor gene. Generation of
mutant mice has been described by Thomas et al.
(1998). Mice were genotyped by Southern blotting of
tail DNA and maintained in the original colony at Duke
University. Mice were fed a standard laboratory diet.
Tubuloglomerular feedback studies
Experiments were done in four wild type (TP +/+),
three heterozygous (TP +/±), and four homozygous
(TP ±/±) mice of both sexes. Body and kidney weights
averaged 30.7  4.7 g and 181.7  30.9 mg in TP +/+,
29.7  0.8 g and 183.3  8.3 mg in TP +/±, and
31.5  3.1 g and 194.2  11.7 mg in TP ±/± mice.
Investigators were blinded as to the genotype of the
animals. Animals were maintained on a standard rodent
chow and tap water.
Mice were anaesthetized with 100 mg kg±1 inactin
i.p. and 100 mg kg±1 ketamine intramuscularly. Body
temperature was maintained at 38 °C by placing the
animals on an operating table with a servo-controlled
heating plate. The trachea was cannulated and a stream
of 100% oxygen was blown towards the tracheal tube
throughout the experiment. The femoral artery was
cannulated with hand-drawn polyethylene tubing for
measurement of arterial blood pressure. The femoral or
jugular vein was cannulated for an intravenous main-
tenance infusion of 2.25 g% bovine serum albumin in
saline at a rate of 0.35 mL h±1. This rate of infusion has
previously been shown to be associated with a urine
¯ow around 2 lL min±1 and a urine osmolarity around
1000 mosm kg±1 (Schnermann et al. 1998) suggesting
adequate hydration, but no overt volume expansion.
The left kidney was approached from a ¯ank inci-
sion, freed of adherent fat and connective tissue, and
placed in a lucite cup adapted for the size of the mouse
kidney. The kidney was covered with mineral oil.
Measurements of early proximal stop ¯ow pressure
(PSF) during loop of Henle perfusion were done to
assess tubuloglomerular feedback (TGF) responsive-
ness. A late proximal tubule segment was identi®ed
from the staining pattern following microperfusion of a
randomly selected proximal segment with the FD&C
stained perfusate. The tubule was blocked with wax, the
pump inserted in the last super®cial proximal segment,
and a pressure pipette connected to a servo null pres-
sure device was inserted into an early proximal segment
recognizable from the widening of the tubular lumen.
When PSF had stabilized, loop of Henle perfusion rate
was altered between 30 and 0 nL min±1 in a random
fashion to assess maximum feedback responses. The
perfusion pipette was then withdrawn, replaced with a
pipette containing the TP receptor agonist U46,619
(10±5 M), and the TGF response to an increase in ¯ow
to 30 nL min±1 was tested again. Perfusion ¯uid was
arti®cial tubular ¯uid (ATF) containing (in mmol L±1):
136 NaCl, 4 NaHCO3, 4 KCl, 2 CaCl2, 7.5 urea,
100 mg (100 mL)±1 FD&C green (Keystone) and
1 g (100 mL)±1 ethanol as a solvent control. U46,619
was prepared as a 10±3 M solution in ethanol and
diluted 100-fold with ATF to yield a concentration of
10±5 M. U46,619-containing solutions were made fresh
for each experiment. At the end of the experiments, the
blood pressure responses to intravenous bolus injec-
tions of U46,619 were tested to functionally verify the
animal's genotype.
Ureteral obstruction
The effect of an acute unilateral ureteral obstruction
was studied in seven wild-type and seven homozygous
TPR knockout mice. Four animals of each strain were
used to examine the effect of acute ureteral obstruction
on proximal tubular pressure. Animals were anaes-
thetized and prepared for micropuncture as described
above. After determining proximal tubular pressures in
several tubules the ureter was ligated close to the kid-
ney. Measurements of tubular pressure were done over
the next 3 h at a rate of 10±20 measurements per hour.
Pressure measurements were averaged for the periods
0±30, 30±60, 60±120 and 120±180 min following
ureteral ligation. Pressure was measured with a servo
null pressure device (WPI, Sarasota, FL).
Three animals of each strain were anaesthetized with
70 mg kg±1 ketamine and 30 mg kg±1 xylazine given
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intraperitoneally. The left ureter was ligated, and the
abdominal incision sutured. 18 h later the animals were
prepared for micropuncture as described above and
10±15 measurements of proximal tubular pressures
were performed using different tubules for each mea-
surement.
Statistical comparisons were made with ANOVA in
association with the Scheffe test, or the Student t-test,
using paired or unpaired comparisons, as appropriate.
RESULTS
Tubuloglomerular feedback studies
Results from these studies are summarized in Table 1.
Mean arterial blood pressures in the three groups of
rats were not different although there was a tendency
for blood pressure to be slightly higher in TP ±/± mice
than in wild-type animals. Similarly, stop ¯ow pressures
(PSF) at zero ¯ow were not signi®cantly different and
averaged 41.9  1.6 (n  15), 41.8  1.7 (n  8)
and 46.0  1.9 mmHg (n  13) in TP +/+, TP +/±,
and TP ±/±, respectively. When ¯ow was increased to
30 nL min±1 PSF fell to 35.5  1.4 mmHg in TP +/+,
to 35.7  1.3 mmHg in TP +/±, and to 38.1  1.8 in
TP ±/± mice. As can be seen in Fig. 1 maximum TGF
responses were not signi®cantly different between the
different TP receptor genotypes.
The effect of luminal perfusion with the TP receptor
agonist U46,619 was performed to verify the absence of
functional receptors in the region of the glomerulus in
the TP knockout mice. Data in Table 1 and Fig. 1 show
that U46,619 signi®cantly enhanced TGF responses in
wild-type animals (from 6.4  0.4 to 10.4  0.8
mmHg; P  0.0005) and in TP +/± mice (from
6.1  0.6 to 10.6  2.8 mmHg; P  0.0005) whereas
no effect was seen in TP ±/± mice (7.9  0.7 vs.
7.7  0.7 mmHg). An original recording of the PSF
changes in response to ¯ow elevations with and with-
out U46,619 in TP +/+ and TP ±/± mice is shown in
Fig. 2.
Measurements of mean arterial blood pressure in
response to intravenous bolus injections of U46,619
are shown in Fig. 3. Injections of 10±60 lg kg±1
U46,619 caused increases in blood pressure by 15±
20 mmHg in TP +/+ and TP +/± mice. The appli-
cation of higher doses led to very transient blood
pressure increases followed by pronounced reductions
in blood pressure that were usually irreversible. In
contrast, in TP ±/± animals U46,619 in doses up to
2 mg kg±1 had only minimal effects on blood pressure
and was tolerated without noticeable haemodynamic
deterioration.
Ureteral obstruction
Measurements of tubular pressure in TP +/+ and
TP ±/± are summarized in Fig. 4. It can be seen that
tubular pressures before obstruction were not different
between TP +/+ and TPR ±/± animals (16.5  1.09
and 18.1  1.31 mmHg, respectively). Tubular pressure
Table 1 Tubuloglomerular feedback
responses in wild-type, heterozygous
and homozygous thromboxane
receptor (TPR) knockout mice and
effect of tubular application of the
thromboxane agonist U46,619
















TPR +/+ 4/15 41.9  1.6 35.5  1.4 103.1  2.9 43.4  1.7 33.0  1.8 103.1  3.0
TPR +/± 3/8 41.8  1.7 35.7  1.3 113.2  4.6 44.1  2.5 35.1  1.8 113.3  4.6
TPR ±/± 4/13 46.0  1.9 38.1  1.8 113.6  2.6 45.2  1.6 37.5  1.7 112.7  2.4
Figure 1 Mean stop ¯ow pressure changes in TP +/+, TP +/± and
TP ±/± mice during loop perfusion with Ringer solution without
(control) and with the TP receptor agonist U46,619 (10±5 M). Vertical
bars are SE. * Signi®cance at P < 0.05 compared with control
perfusion.
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increased following ureteral obstruction in both strains
of mice, but reached higher levels in TP ±/± mice.
Differences in tubular pressure between TP +/+ and
TP ±/± were signi®cant at time points longer than
30 min following obstruction. Measurements of tubular
pressure performed 18 h after unilateral ureteral
obstruction showed the previously described return to
essentially normal values in TP +/+ mice (16.5  1.06
vs. 17.9  0.24 mmHg; P  0.31). In contrast, tubular
pressure remained signi®cantly higher than control in
TP ±/± animals (18.1  1.3 vs. 24.7  0.67 mmHg,
respectively; P  0.01). Blood pressure of TP +/+ and
TPR ±/± mice during these experiments are shown in
Fig. 5. It can be seen that blood pressure levels in the
acute studies were slightly, although not signi®cantly
higher in TP ±/± than in TP +/+ mice.
DISCUSSION
The current experiments were performed in mice with a
knockout mutation in the TP receptor gene for a fur-
ther elucidation of the role of thromboxane in renal
vasoconstriction. Absence of functional TP receptors in
these mice has been veri®ed previously by demon-
strating absent expression of TP receptor mRNA in
thymocytes and lack of TP agonist binding in renal
Figure 2 Original recording of stop
¯ow pressure (PSF, upper tracings) and
arterial pressure (AP, lower tracings) in
a wild-type (TP +/+) and
homozygous TP knockout mouse
(TP ±/±) during loop perfusion
without (control) and with TP agonist
(U46,619). Periods of loop perfusion at
30 nL min±1 are indicated by black
boxes.
Figure 3 Changes in mean arterial blood pressure (MAP) in wild-type
(TP +/+), heterozygous (TP +/±) and homozygous thromboxane
receptor (TP ±/±) knockout mice during intravenous bolus injections
of the TP receptor agonist U46,619. Bars indicate SE.
Figure 4 Time dependency of change in tubular pressure following
ureteral obstruction in wild-type (TP +/+) and homozygous throm-
boxane receptor (TPR ±/±) knockout mice. Values are means and
bars indicate SE. * P < 0.05, ** P < 0.01 (compared with TPR +/+).
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cortex and medulla (Thomas et al. 1998). Lack of TP
receptors is also consistent with the resistance of
TP ±/± mice to bolus injections of the TP receptor
agonist U46,619 in doses that cause marked blood
pressure reductions and death in wild-type animals.
This haemodynamic collapse that has also been
observed in a previous study is presumably the conse-
quence of platelet aggregation and subsequent throm-
botic events (Thomas et al. 1998).
The present studies of the TGF system in TP
receptor knockout mice show that TGF responses to a
saturating increase of macula densa NaCl concentration
are not signi®cantly altered in TP ±/± animals com-
pared with TP +/+ or TP +/± mice. On the basis of
previous studies in rats during acute pharmacological
inhibition of TP receptors or TP synthesis we had
expected a reduction in maximum TGF response
magnitude in the TP ±/± animals (Morsing et al. 1989,
Welch & Wilcox 1988, 1990). However, the effect of
interference with the action of thromboxane on TGF
responses is sometimes relatively small (Franco et al.
1988, Morsing et al. 1989, Brannstrom & Arendshorst
1999), and it is possible that we were unable to detect a
small difference owing to the necessarily non-paired
design of our experiments. On the other hand, the
contribution to the TGF vasoconstrictor response seen
under acute conditions of TP receptor inhibition may
not be evident when TP receptors are chronically non-
functional. It has been suggested that acute TP receptor
inhibition may affect TGF in part by a reduction in
NaCl transport, an effect that one may expect to be
compensated during prolonged removal of TP in¯u-
ences (Welch & Wilcox 1992). The cause for the
absence of clear differences between TP ±/± and
TP +/+ mice does not seem to be related to absence
of a capacity for TP receptors to modulate TGF in the
wild type animals as an enhancement of TGF responses
was observed with local application of the TP agonist
U46,619. This is consistent with earlier micropuncture
studies in rats (Welch & Wilcox 1992, Welch et al. 1997)
and with the regular observation of abundant expres-
sion of TP receptors in the glomerular region of various
species including mice (Asano et al. 1996, Bresnahan
et al. 1996, Takahashi et al. 1996). It seems reasonable
to assume that the effects of TP under normal condi-
tions are limited by low expression of TP synthase and
TP production rates (Farman et al. 1987, Endoh et al.
1997, Tsutsumi et al. 1997). It is also possible that the
production of vasorelaxant prostaglandins from the
same pool of arachidonic acid balances the constrictor
actions of TP activation. In general, TP receptor inhi-
bition does not measurably affect renal functional
parameters such as renal blood ¯ow and glomerular
®ltration rate (Purkerson et al. 1986, Jackson et al. 1988,
Welch & Wilcox 1990). This further supports the
notion that the effects of thromboxane on renal vas-
cular resistance under non-stressed conditions in the
healthy kidney are marginal.
Numerous studies have shown that both unilateral
and bilateral ureteral obstruction initially cause a vaso-
dilator response that is followed by a progressive and
persistent vasoconstriction (Klahr & Harris 1992). The
most direct evidence for this biphasic response came
from measurements of renal blood ¯ow in the dog
showing that kidneys are hyperperfused for 2 to 3 h
followed by progressive reductions in blood ¯ow such
that at times longer than 18 h renal blood ¯ow is
reduced to half the control value (Moody et al. 1975).
The biphasic pro®le in renal blood ¯ow following
unilateral ureteral obstruction is mimicked by parallel
changes in intratubular pressure showing an initial rise
followed by a reduction to normal values by 18 h or
longer (Dal Canton et al. 1979). The change in renal
blood ¯ow is caused by inverse changes in renal vas-
cular resistance with the vasomotor response being
predominantly located in the afferent arterioles (Dal
Canton et al. 1979, Klahr & Harris 1992).
There is evidence that angiotensin II and throm-
boxane acting in concert are responsible for the vaso-
constriction of afferent arterioles elicited by ureteral
obstruction (Klahr & Harris 1992). The present ®nding
that intratubular pressure after 18 h of ureteral
obstruction was signi®cantly higher in the TP ±/± mice
than in control is in agreement with this notion.
Changes of intratubular pressure under conditions of
complete ureteral obstruction have been shown to
parallel changes of tubular stop ¯ow pressure
(Arendshorst et al. 1974, Persson et al. 1984, Tanner
Figure 5 Mean arterial blood pressure in wild-type (TP +/+) and
homozygous thromboxane receptor (TP ±/±) knockout mice before
and during different times of unilateral ureteral obstruction. Values
are means and bars indicate SE.
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1985) and therefore can serve as an index of glomerular
capillary pressure. Thus, the greater rise in tubular
pressure in the TP ±/± mice suggests that throm-
boxane formed in response to ureteral obstruction acts
to counteract the full extent of the initial vasodilator
response to obstruction. Increased formation of
thromboxane during ureteral obstruction has been well
documented in previous studies (Morrison et al. 1977,
Klahr & Harris 1992). After 18 h of ureteral obstruc-
tion intratubular pressure in TP +/+ mice had returned
to control in agreement with earlier observations
(Arendshorst et al. 1974, Dal Canton et al. 1979, Pers-
son et al. 1984, Tanner 1985, Klahr & Harris 1992).
Tubular pressure in TP ±/± mice at 18 h had also fallen
signi®cantly compared with the acute phase, but it
remained higher than in wild-type animals. Thus while
TP-induced vasoconstriction appears to be responsible
for some of the reduction in intratubular pressure other
vasoconstrictor mechanism(s) operate to prevent per-
sistent increases in tubular pressure.
In summary, the current experiments show that
TGF responses to maximum ¯ow stimulation are
identical between wild-type and homozygous TP
receptor knockout mice suggesting that chronic
alterations in TP receptor expression and TP formation
are unlikely to regulate TGF response magnitude and/
or TGF sensitivity. The role of thromboxane as a
regulator of vascular tone under physiological
conditions studied may be limited. On the other hand,
TP receptor de®ciency is accompanied by exaggerated
vasodilatation during short-term unilateral ureteral
obstruction and attenuated vasoconstriction during
longer lasting obstruction, consistent with the notion
that thromboxane participates in the vascular response
to ureteral occlusion.
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